Evidence for IGF/IGF-1R signaling conferring lenvatinib resistance in HCC still has not been investigated; however, some IGF/IGF-1R-crosstalked signaling have been found to be involved in lenvatinib resistance. The gene discussed is IGF1R; the disease is hepatocellular carcinoma.